Ache Laboratorios Farmaceuticos SA-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Ache Laboratorios Farmaceuticos SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011800
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ブラジル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ache Laboratorios Farmaceuticos SA (Ache) is a drug company that offers generic products. The company provides prescription, prescription free, generic, dermatological, dermocosmetic drugs, nutraceuticals and probiotic products. Its activities include research, development, production, distribution and commercialization of biotechnology medicines. Ache manufactures cephalosporin antibiotics and commercialization of functional foods. The company exports drugs Canada, Colombia, Peru, Ecuador, Chile, Bolivia, Cista Rica, Venezuela, Mexico, the US and Dominica Republic. It operates through its industrial plants located in Guarulhos, Sao Paulo and Anapolis, Brazil. Ache is headquartered in Guarulhos, Brazil.

Ache Laboratorios Farmaceuticos SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Ferring International Center Enters into Agreement with Ache Laboratorios Farmaceuticos 10
BioGaia Enters Into Distribution Agreement With Ache Labs 11
Hypermarcas Enters Into Joint Venture With Ache Labs, EMS Participacoes And Uniao Quimica Farmaceutica 12
Licensing Agreements 13
Oxford Nutrascience Enters Into Licensing Agreement With Ache Laboratorios 13
Acquisition 14
Ache Laboratorios Farmaceuticos Acquires Nortis Pharma 14
Pfizer, Novartis And Abbott Labs Reportedly Plan To Bid For Ache Labs 15
Ache Laboratorios Farmaceuticos SA – Key Competitors 17
Ache Laboratorios Farmaceuticos SA – Key Employees 18
Ache Laboratorios Farmaceuticos SA – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Joint Venture 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Key Facts 2
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ache Laboratorios Farmaceuticos SA, Deals By Therapy Area, 2011 to YTD 2017 8
Ache Laboratorios Farmaceuticos SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Ferring International Center Enters into Agreement with Ache Laboratorios Farmaceuticos 10
BioGaia Enters Into Distribution Agreement With Ache Labs 11
Hypermarcas Enters Into Joint Venture With Ache Labs, EMS Participacoes And Uniao Quimica Farmaceutica 12
Oxford Nutrascience Enters Into Licensing Agreement With Ache Laboratorios 13
Ache Laboratorios Farmaceuticos Acquires Nortis Pharma 14
Pfizer, Novartis And Abbott Labs Reportedly Plan To Bid For Ache Labs 15
Ache Laboratorios Farmaceuticos SA, Key Competitors 17
Ache Laboratorios Farmaceuticos SA, Key Employees 18
Ache Laboratorios Farmaceuticos SA, Subsidiaries 19
Ache Laboratorios Farmaceuticos SA, Joint Venture 19

★海外企業調査レポート[Ache Laboratorios Farmaceuticos SA-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Corning Incorporated:企業の戦略・SWOT・財務情報
    Corning Incorporated - Strategy, SWOT and Corporate Finance Report Summary Corning Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Jaiprakash Power Ventures Ltd (JPPOWER):電力:M&Aディール及び事業提携情報
    Summary Jaiprakash Power Ventures Ltd (Jaiprakash Power) is a power utility. It plans, develops, implements, and operates electric projects. The company produces electricity using hydro and coal sources. Jaiprakash Power also has development interests in the Hirong hydroelectric project and the Lowe …
  • BioLamina AB:製薬・医療:M&Aディール及び事業提携情報
    Summary BioLamina AB (BioLamina) is a biotechnology company that focuses on the development, manufacture and distribution of cell culture reagents intended for culturing primary cells. The company offers a wide portfolio of chemically defined and xeno-free laminin proteins. Its product portfolio inc …
  • Black Hills Power Inc:電力:M&Aディール及び事業提携情報
    Summary Black Hills Power Inc (Black Hills), a subsidiary of Black Hills Corp, is a power company that generates, transmits and distributes electricity. The company generates electricity through coal, gas, and oil resources. Its services include electricity and natural gas transmission and distribut …
  • Fichtner GmbH & Co KG:企業の戦略的SWOT分析
    Fichtner GmbH & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • MDU Resources Group, Inc.:企業の戦略・SWOT・財務分析
    MDU Resources Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary MDU Resources Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Synexus Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Synexus Ltd (Synexus), a subsidiary of Synexus Clinical Research Limited, is a site management organisation that offers patient recruitment and trial management services. The company services include feasibility assessment, project management, patient engagement, patient-centric clinical tri …
  • Attunity Ltd (ATTU):企業の財務・戦略的SWOT分析
    Summary Attunity Ltd (Attunity) is a technology company that provides data management software, cloud database replication solutions, and google cloud database tools. The company provides data management software solutions that enable access, sharing, management, and distribution of data. It offers …
  • Cipla Limited:企業の戦略・SWOT・財務分析
    Cipla Limited - Strategy, SWOT and Corporate Finance Report Summary Cipla Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Radiomedix Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Radiomedix Inc (Radiomedix) is a biotechnology company that develops and commercializes radiopharmaceuticals for diagnosis and therapy of cancer. The company’s products include radioisotopes, fully automated synthesizers, semi-automated synthesizers, GMP cassettes and consumables, smartmedix …
  • Histogen Inc-医療機器分野:企業M&A・提携分析
    Summary Histogen Inc (Histogen) is a regenerative medicine company that develops novel therapies. The company offers research and develops cell based products. Its products include insoluble human extracellular matrix and a soluble complex of proteins. Histogen’s proprietary technologies are used in …
  • NTN Corporation:企業の戦略・SWOT・財務情報
    NTN Corporation - Strategy, SWOT and Corporate Finance Report Summary NTN Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Fresenius Kabi USA LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Fresenius Kabi USA LLC (Fresenius Kabi), a subsidiary of Fresenius Kabi AG, is a pharmaceutical and medical device company which provides lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. It provides products and services to critically and chronically il …
  • Alesi Surgical Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Alesi Surgical Ltd (Alesi Surgical), formerly Asalus Medical Instruments Ltd, is a medical device company that develops and markets laparoscopic surgical smoke handling systems. The company offers Ultravision, a system that removes laparoscopic surgical smoke without the need for gas exchang …
  • BlackRock Inc:企業のM&A・事業提携・投資動向
    BlackRock Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BlackRock Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • QEP Resources Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    QEP Resources Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary QEP Resources Inc (QEP) is an independent oil and natural gas exploration and production company. It has operating interests in Northern Region chiefly in North Dakota, Wyoming and Utah; and Southe …
  • Spectrum Health System:企業の戦略的SWOT分析
    Spectrum Health System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Lea County Electric Cooperative Inc:企業の戦略的SWOT分析
    Lea County Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Sembcorp Industries Ltd (U96)-石油・ガス分野:企業M&A・提携分析
    Summary Sembcorp Industries Limited (Sembcorp) is a diversified energy, water and marine company. The company’s utilities division provides energy and water to industrial and municipal customers. Its energy operations include power generation, steam production and supply and natural gas import suppl …
  • MannKind Corp (MNKD):医療機器:M&Aディール及び事業提携情報
    Summary MannKind Corp (MannKind) is a biopharmaceutical company that develops and commercializes inhaled therapeutic products for patients suffering from diabetes and pulmonary arterial hypertension. Its flagship product, Afrezza is a US FDA approved rapid-action inhaled insulin used to control high …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆